Option Care Health, Inc. (OPCH)
Company Description
Option Care Health, Inc. offers home and alternate site infusion services in the United States.
The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations.
Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Country | United States |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 7,802 |
CEO | John C. Rademacher |
Contact Details
Address: 3000 Lakeside Dr, Suite 300n Bannockburn, Illinois 60015 United States | |
Phone | 312 940 2443 |
Website | optioncarehealth.com |
Stock Details
Ticker Symbol | OPCH |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001014739 |
CUSIP Number | 68404L201 |
ISIN Number | US68404L2016 |
Employer ID | 05-0489664 |
SIC Code | 8082 |
Key Executives
Name | Position |
---|---|
John C. Rademacher | Chief Executive Officer, President and Director |
Michael H. Shapiro | Chief Financial Officer and Senior Vice President |
Collin G. Smyser | General Counsel and Corporate Secretary |
Richard P. Denness | Non-Executive Employee |
Luke Whitworth | Chief Operating Officer |
Brett Michalak | Chief Information Officer |
Caroline Budde | Senior Vice President and Chief Compliance Officer |
Michael Bavaro | Chief Human Resources and Diversity Officer |
Julie Koenig | Senior Vice President of Operations |
Cari Reed | Senior Vice President of Quality and Clinical Services |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 14, 2024 | 8-K | Current Report |
Feb 28, 2024 | 144 | Filing |
Feb 22, 2024 | 10-K | Annual Report |
Feb 22, 2024 | 8-K | Current Report |
Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Jan 23, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Dec 29, 2023 | 8-K | Current Report |
Dec 11, 2023 | 8-K | Current Report |
Oct 25, 2023 | 10-Q | Quarterly Report |
Oct 25, 2023 | 8-K | Current Report |